Read i bc27f85be50b71b1 Online
Authors: Unknown
serum levels III parathyroid disorders,
classlhc:1tion of, 444-446
6861, 687--{;88
cleansing and debridement in, 459
urine levels In parathyroid disorders,
coagulation zones in, 439, 439f
687
complications of, 443, 444
Calcium algi nates III wound care, 492t
systemic, 441, 441 t, 465
Calcium channel blockers, 854[
depth of, 446, 448f, 449t
Calculi
electrical,441--443
gallstones, 544-545
excision and grafting in, 454--459, 456t
urmary, 583-584
extent of, 445f, 445--446, 447t
in kidneys, 566, 579-580
fluid administration in, 452, 465
percutaneous nephroscopic,
infection control in, 452--453
removal of, 596
inhalarion injury in, 450-451
surgery In, 596-597
lightning, 443-444
Cancer, 331-359. See also Tumors
Lund and Browder formula on, 446,
Cannabinoids in nausea and vomiting,
447t
846t
management of, 447-467
Capillaries, 364
pain in, 453, 465
characteristics of, 365t
assessmem of, 463
refill rime, 371 t
pathophysiology of, 439--444
Carbohydr:ue antigen 19-9,5 17r
physical therapy examinarion in, 459-
Carbon dioxide
464
arterial partial pressure, 112
physical therapy interventions in,
in cardiac evaluation, 31
465-467
in mechanical ventilation, 821 t
physiologic sequelae of, 439--441,
hypercapnia. 1 13
440f
permiSSive, 82 J t
posirioning of patient in, 467, 467t
transport of, 97
from radiation, uluaviolet and ioniz-
Carbon monoxide
ing, 444
diffusing capaciry of, J29t
resuscitation in, 450--452
poisomng from, 451
rule of nines in, 445f, 445--446
Carboplarin, 854t
shock in, 452
Carclnoembryonlc antigen levels, 508r
skin substitutes in, 457t--458t
Carcinoma, 332, 333t
temperature maintenance in, 453
of lungs, 344
thermal, 441, 442t
of skin, 356-357
INOEX
933
of thyroid gla nd, 657t
edema in. 368, 386t, 428-429,
Cardiac c ycle, 6
479-480
Cardiac index, 6-7, 788t
pulm onar y, 142
Cardiac output, 6-9
electroc ar diog raphy in, 74-79, 82-
111 heart failure, 44
88
measurement of, 788t-789r
embolism, 392, 401-402
Cardiomyopathy, 44
embolization therapy in, 326, 422-
classification of, 46 t
423
dynamiC c ardiomyoplasty ill, 57
endarterect omy in, 425-426
in HIV infection and AIDS, 635t
func t ional classification of, 48-49,
ventncular assist device in, 832-836
491
Cardiomyoplasry, dyn amic, 57
heart failure, 44-49, 58, 59
C ar diopulmonary resuscitarion decihyperlension, 392-395
sions, 755
incidence 0(, 1
Cardiovascular system, 1-88
infections of heart, 624-625
anatomy of
management of
blood vessels in, 364, 364t, 365
111 cardiac di sorders, 50-69
heart 111, 2, 3f
in vascular disorders, 414-428
an est hesia aff ecting, 872
10 mechanical ventilatio n, 824
blood and blood vessels 10, 363-
myocardial ischemia and infarc430
tion, 39-43, 50-53
disorders of. 39-69. See also specific
pathophysiology of
dIsorders
in cardiac disorders, 39-49
aneurysms. 388-390, 426-438
in vascular disorders, 384-404
arrhythmias, 43-44
pericardial, 44, 47t
anerial, 384-399
physical therapy in, 61-69, 428-430
aneriovenous malformations, 313-
In Circulatory assist devices,
314,403
837-838
111 ath eroscl erosis, 384-388
go,l, of, 61-62, 428
111 bed rest, prolonged, 754t
response [0 exercise in, 62, 64f
in burns, 441 t, 443, 444
wi thholding 0(, 62, 63t
bypass grafting in
postopcr:uive, 872, 873
coronary arrery. 52-53
Raynaud's disease and phenomeperl pheral,423-425
non in. 397-398
c:lrdlomyoparhy, 44, 461
risk factors for, 14, 14r
circ utuory assist deVices in, 829-
skin disorders in, 402, 403, 468-
838
470,479-480
compa rtment syndro me in, 399
syncope in, 318
congenital vascular malformations,
thrombolytic th erapy in, 50, 423
403-404
thrombosis, 392, 400-401
drug therapy in, 59, 60-61, 393,
valvular, 44, 45(, 57-58
8431
vasculitis. 395-397
�-adrenergjc blockers in, 853t
vcnou',399-403,468-470
calcIUm channel blockers in,
in Wegener's granulomatosis, 396
8541
wound healmg in, 475
digit aliS 10, 59, 60t, 8671
evaluation of, 13-39
dIUretics in, 861 t
angiography in, 38, 370, 376. See
nitrates in, 866t
also Angiography
symparhomimetics in, 8671
311scultafion in, 22-24, 24f, 370, 609
thromboly tic, 50, 423, 868t
blood pressure measurement in,
vasodibtOr, 869r
19-22,370
934
AClITE CARE HANDBOOK FOR I'HYSICAL THERAPISTS
Cardiovascul3r system-continued
urinary
in cardiac disorders, 13-39
Foley catheters Ln, S05t
diagnostic and laboratory measures
suprapubic, S02t
in, 25-39, 370-376
Texas catheters in, S03t
history taking in, 13-15,367
Cecum,504t
physical examination in, 15-24,367-
Celluliris, 630
370
Central cord syndrome, 3 lit
in vascular disorders, 367-376
Central nervous system, 260-274
in wounds, 479-480
brain in, 260--274. See also Brain
heart in. See Heart
degenerative disorders of, 319-321
structure and function of, 2-12, 364-
infections of, 625-629
366
spinal cord in, 274. See also Spinal
blood vessels in, 5t, 364, 364t,
cord
365r
Structure and function of, 260-274
primary structures in, 4t-5t
trauma of, 305-310
Carmustine, 854t
Central venous catheters, 795t
Carotid arteries, 272, 273t
peripheral inserted, S02t
Doppler imaging of, 302
tunneled, S04t
endarterectomy of, 425-426
Cephalosporins, 848t
Carpal fractures, 189
Cerebellar arteries, 273t
Cartilage transplantation, autologous,
Cerebellum, snucrure and function of,
219-220, 22 I f
260, 267r-268r
Cast brace, 220
Cerebral arteries, 273t
CastS, 220-224
aneurysm of, 314, 390
bivalve, 220
angiography of, 302
complications of, 220, 223, 224
spasm of, 315
serial, 220
Cerebrospinal fluid
types of, 220, 222t-223t
circulation of, 269-271, 271£
Catecholamines, 671
drainage of, 324(, 798t
Catheterization, 794-808
in hydrocephalus, 315-316
cardiac, 36-38
intracranial pressure of, 321-324,
precautionary period after, 38, 52
791-794
central venous, 795t
increased. See Intracranial pressure
peripherally inserted, 802t
increase
tunneled, 804t
normal range in, 321
epidural, in pain management, 882t-
leakage of. 316
883r
lumbar punCfure for analysis of, 303
for hemodialysis, 590, 591 f, 795t